THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE
The COVID-19 pandemic was announced by the Indonesian government on March 2nd, 2020 has an impact on almost all aspects of life. To prevent the COVID-19 pandemic from spreading, the government has adopted the LSSR, CARE, and Vaccination policies. This situation has an impact on companies, for pharma...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Russian Journal of Agricultural and Socio-Economic Sciences
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f721592f366d430c9aee8f209bd7d0a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f721592f366d430c9aee8f209bd7d0a1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f721592f366d430c9aee8f209bd7d0a12021-12-04T07:59:54ZTHE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE10.18551/rjoas.2021-11.012226-1184https://doaj.org/article/f721592f366d430c9aee8f209bd7d0a12021-11-01T00:00:00Zhttps://doaj.org/toc/2226-1184The COVID-19 pandemic was announced by the Indonesian government on March 2nd, 2020 has an impact on almost all aspects of life. To prevent the COVID-19 pandemic from spreading, the government has adopted the LSSR, CARE, and Vaccination policies. This situation has an impact on companies, for pharmaceutical companies, this is expected to have a positive impact. This study aimed to find out the impact of the COVID-19 pandemic and analyze differences in financial performance as measured by Current Ratio/CR, Debt Ratio/DR, Total Asset Turnover/TATO, Return on Equity/ROE, and Price Earning/PE in pharmaceutical companies listed in Indonesia Stock Exchange 2019-2020. By using a paired sample t-test, the following were found: the financial performance of pharmaceutical companies as measured by CR decreased during the COVID-19 pandemic. Meanwhile, financial performance as measured by DR, TATO, ROE, and PE increased during the COVID-19 pandemic. There was no difference in the financial performance of pharmaceutical companies as measured by CR, DR, TATO, ROE, and PE between before the COVID-19 pandemic and during the COVID-19 pandemic.Ediningsih S.I.Satmoko A.Russian Journal of Agricultural and Socio-Economic Sciencesarticlecurrent ratiodebt ratiototal asset turnoverreturn on equityprice earningAgriculture (General)S1-972ENRURussian Journal of Agricultural and Socio-Economic Sciences, Vol 119, Iss 11, Pp 3-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
current ratio debt ratio total asset turnover return on equity price earning Agriculture (General) S1-972 |
spellingShingle |
current ratio debt ratio total asset turnover return on equity price earning Agriculture (General) S1-972 Ediningsih S.I. Satmoko A. THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE |
description |
The COVID-19 pandemic was announced by the Indonesian government on March 2nd, 2020 has an impact on almost all aspects of life. To prevent the COVID-19 pandemic from spreading, the government has adopted the LSSR, CARE, and Vaccination policies. This situation has an impact on companies, for pharmaceutical companies, this is expected to have a positive impact. This study aimed to find out the impact of the COVID-19 pandemic and analyze differences in financial performance as measured by Current Ratio/CR, Debt Ratio/DR, Total Asset Turnover/TATO, Return on Equity/ROE, and Price Earning/PE in pharmaceutical companies listed in Indonesia Stock Exchange 2019-2020. By using a paired sample t-test, the following were found: the financial performance of pharmaceutical companies as measured by CR decreased during the COVID-19 pandemic. Meanwhile, financial performance as measured by DR, TATO, ROE, and PE increased during the COVID-19 pandemic. There was no difference in the financial performance of pharmaceutical companies as measured by CR, DR, TATO, ROE, and PE between before the COVID-19 pandemic and during the COVID-19 pandemic. |
format |
article |
author |
Ediningsih S.I. Satmoko A. |
author_facet |
Ediningsih S.I. Satmoko A. |
author_sort |
Ediningsih S.I. |
title |
THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE |
title_short |
THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE |
title_full |
THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE |
title_fullStr |
THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE |
title_full_unstemmed |
THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE |
title_sort |
impact of the covid-19 pandemic on the financial performance of pharmaceutical companies listed on indonesia stock exchange |
publisher |
Russian Journal of Agricultural and Socio-Economic Sciences |
publishDate |
2021 |
url |
https://doaj.org/article/f721592f366d430c9aee8f209bd7d0a1 |
work_keys_str_mv |
AT ediningsihsi theimpactofthecovid19pandemiconthefinancialperformanceofpharmaceuticalcompanieslistedonindonesiastockexchange AT satmokoa theimpactofthecovid19pandemiconthefinancialperformanceofpharmaceuticalcompanieslistedonindonesiastockexchange AT ediningsihsi impactofthecovid19pandemiconthefinancialperformanceofpharmaceuticalcompanieslistedonindonesiastockexchange AT satmokoa impactofthecovid19pandemiconthefinancialperformanceofpharmaceuticalcompanieslistedonindonesiastockexchange |
_version_ |
1718372829652582400 |